Package 51655-613-52

{"route": ["ORAL"], "spl_id": "494f2b48-27b0-0214-e063-6394a90a8f2f", "openfda": {"unii": ["YRZ789OWMI"], "rxcui": ["617312"], "spl_set_id": ["f32c8a4f-dee9-86a0-e053-2995a90a3388"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-613-52)", "package_ndc": "51655-613-52", "marketing_start_date": "20221115"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-613-83)", "package_ndc": "51655-613-83", "marketing_start_date": "20230215"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "51655-613_494f2b48-27b0-0214-e063-6394a90a8f2f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "51655-613", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE", "strength": "10 mg/1"}], "application_number": "ANDA090548", "marketing_category": "ANDA", "marketing_start_date": "20221115", "listing_expiration_date": "20271231"}